APART FROM ANTI INFLAMMATORY , ANALGESIC & ANTIPYRETIC
PROPERTIES
R. COMPOUND BEHAVES LIKE ANTIEDEMATOUS TOOL
A CONTROLLED CLINICAL STUDY WITH R.COMPOUND
By
Dr. M. BALAKOTI
REDDY, MDS
Assistant Professor, Dept. of Oral Surgery &
Maxillo – Facial Surgery,
Dr. K.S. BHAT. MDS
Director of Dental Studies, Department odf Oral Surgery
& Maxillo – Facial Surgery
Dr. CH. BHASKER RAO, MDS
Associate Professor, Department of Oral Surgery
& Maxillo – Facial Surgery,
College of Dental Surgery, Manipal – 576 119
INTRODUCTION
Surgeons from ancient day
have found it necessary to improve upon their methods, medication, techniques
and instrumentation to overcome their problems, to make surgery easy for the patients.
The traumatic swellings and their complexities continue to disturb the surgeons
in general and the oral surgeons in particular. Acute trauma and its
consequences following removal of the impacted 3rd molars is of very
common occurrence.
Numerous anti-inflammatory
drugs ranging from basic aspirin, through the Phenylbutazone group,
Indomethacine, Ibuprofen etc, are being used with varying degrees of successful
therapeutic values but have their corresponding side effects. Because of the
variable results obtainable with these drugs, investigators continue to seek
more and more effective methods of treatment for the management of traumatic
swellings. R. compound, an ayurvedic drug, is claimed to possess significant
anti-inflammatory and analgesic properties. '4 The reported freedom from toxic
effects even on prolonged use was a strong consideration to take up this drug
for a fair clinical trial, the results of which are being presented here.
In the present study, R.
Compound was submitted to a clinical trial with a random sample of 60 patients
undergoing surgical removal of impacted mandibular third molars to evaluate
the efficacy of the drug in the control of post-operative complications, with
particular reference to trismus, swelling and pain.
R. Compound is an
indigenous drug manufactured by Messrs. Alarsin Pharmaceuticals, Bombay,
containing the following ingredients:
Mafiayograj Guggul with
Gold Bhasma: 200 Mg.
Maharasnadi Quath: 67 mg.
1. Guggul:
English:-
Indian Bedellium - Salai Tree Kannada-Guggula
Tamil
- Gukkulu; Maisatchi Kunjiliyam Telugu - Maisakshi Guggulu
Latin
- Balasmodendrom Mukul
It is an Oleo resin
containing volatile oil, gum resin and a bitter principle. It is excerted
through the skin, mucous membrane and kidneys and during the course of its
excretion, exerts an anti-inflammatory action. Ramachandra observed that R.
Compound has got anti-suppurative properties 12
2. Maharasnadi quath is prepared
by processing twenty five different herbal drugs. Its chief ingredient is
"Rasna".
English
- Alpinea chinensis
Kannada
- Maharasnadivadi
Tamil
- Chittrattai
Telugu
- Sanna rashtram
Rasna has antirheumatic,
analgesic, anti-inflammatory and antipyretic actions. It is excreted through
skin and kidneys.
Gold, which is a
constituent of R. Compound is a drug which has been reputed for its anti-inflammatory
properties from time immemorial. Unfortunately, gold is highly toxic and fraught
with dangers of severe reactions. Many heavy metals like Arsenic, Mercury,
Bismuth having such properties, which have been used extensively in the past,
have been replaced by potent and specific chemo-therapeutic agents.
In Ayurveda, which is the
ancient system of Indian Medicine, heavy metals are made less toxic by reducing
them into an `Ash' form by special processes. This ash is known as `Bhasma' and
can be used for prolonged periods without any side reactions, which are usually
associated with the use of salts of heavy metals.
R. Compound having
Gold-Bhasma in small quantities, makes it safe even on prolonged use. Gold in
`Ash' form has anti-inflammatory properties. It acts as a "General
metabolic stimulant" and activates reticulo endothelial system. It also
acts as an antiseptic. ' Today however, these Ayurvedic concepts of diseases
and treatments yet remain to be explained in terms of modern medical terminology.
The review of literature
reveals the great diversity of opinions prevailing in this field. External
thermal application has been reported to be beneficial in reducing edema and
pain by Hennessy 4 and Mead . Favourable clinical response on administration
of antihistamines have been observed by Silverman 's and Wohlgenutu'9 . However
Lucin 8 , Snyder ", Keesling and Hinds s pointed out that there is no
significant effect of antihistamines in reducing post-operative pain, swelling,
trismus and haemorrhage. Cortisones have been successfully employed by Ross et
al 13 in acute traumatic conditions of the oral cavity. Extensive studies
carried out on Oxyphen-butazone and Indomethacine to study the
anti-inflammatory effect show that they are effective in controlling
post-operative sequlae. However, it has been observed that they are riot
completely safe on prolonged use and have side effects.
Freedman 3
observed reduction of oedema by using a combination of anti-inflammatory drugs,
prednisolone and a water soluble bioflavonoid, in patients undergoing full
mouth extractions. However, he pointed out that the danger of spread of
infection, delayed repair, adrenal suppression and altered metabolic process
does not advocate the use of these drugs in all cases.
Enzymes in different forms
have been used for control of post-operative oedema, trismus and pain in oral
surgical procedures. Fleuchaus 2 and Shuttee '5 injected hyaluronidase with
local anaesthetics, Krause ' administered a combination of enzymes orally,
Patrick'°, Patrick and Horton " and Tejinder Singh'3 used papase, an
extract of a plant carica papaya and Irving Innerfields 5 used streptokinase.
The results of all these studies indicate favourable response.
There were no reports in
the reviewed literature of the use of R. Compound in dentistry. R. Compound
has been tried extensively by orthopaedic surgeons in India in rheumatoid arthritis,
osteo-arthritis, synovitis etc., with promising results. 1,12,41 In view of
this, the study of clinical application of R. Compound in dentistry seems
relevant as these ayurvedic preparations are less expensive, readily available
and acceptable to rural population amongst whom ayurveda enjoys a special
confidence.
R. Compound was
submitted to a clinical trial on patients undergoing surgical removal of
impacted mandibular third molars.
This was done mainly with an aim to ascertain whether R. Compound has got
beneficial effects in reducing the post-operative discomfort, trismus,
swelling and pain.
Sixty patients with
impacted mandibular third molars were selected for this study. Patients of both
sexes selected at random constituted the sample. Out of this sixty, forty two
were males and eighteen were females in the age group of 19 to 42 years. Among
this sixty, twenty two were having bilateral impacted third molars. All the
cases were evaluated adequately and patients presenting impaction of similar
degree were selected, so that trauma inflicted during surgery was approximately
the same. All patients selected had no pre-operative symptoms like pain,
swelling and trismus. This has permitted proper evaluation.
These patients were
divided into two groups of thirty each in the experimental and control groups.
The experimental group received the tablet R. Compound, 2 tablets 3 times a day
for 5 days, starting from the day of operation. The control group received none
of the anti-inflammatory drugs. All patients were put on capsule Tetracycline,
Resticline 250 mg., six hourly from the day of operation for 5 days.
Having observed all the
general principles of surgery, the teeth were extracted under local
anaesthesia, 2cc of 2% lignocaine hydrochloride with adrenaline 1:80.OOO.The
surgical technique used for the extraction of the teeth was the bur technique
The patients were advised intermittent ice application over the operated area
for a period of two hours postoperatively. All the patients wer instructed to
follow the usual precautions and were advised to report to the department for
check-up on the first, second, third, fourth, fifth and seventh post-operative
days for clinical evaluation. Post-operative check-up consisted of evaluation
of the degree of pain, swelling, trismus and incisal mouth opening. The mouth
opening was recorded pre-operatively and on all the post-operative check-up
days. Pain and swelling were graded and recorded as nil, mild,moderate,
moderately severe and severe in degree.
In case of bilateral
impactions the extractions were done in two sessions so that one side served
as experimental and the subsequent extraction on the opposite side served as
control.
The present study
indicated that R. Compound is a potent anti-inflammatory agent with
recognizable analgesic effects. As with the other anti-inflammatory agents, the
mechanism of action of R. Compound is not known. The effects of R. Compound
assessed and expressed in term of scvelling, trismus and pain show the good
beneficial effects of this drug on the post-operative features in the group of
patients subjected to the study.
Swelling: The results of
assessment of swelling are given in Table No. 1. The resolution of the oedema
is a relative phenomenon depending much on the healing powers and resistance
of the patient. Qualitatively R. Compound behaves like anti-edematous of
the anti-inflammatory, anti-pyretic type of drug. Only 40% of the patients
treated with R. Compound experienced moderate swelling as compared to 53%
severe and 47% moderately revere swelling in the control group on the first
post-operative day. A marked difference in the reduction of the swelling was
evident on the second post-operative day when 68% of the treated and only 12%
of the control groups experienced mild or/no swelling. On the third postoperative
day, 87% of the treated and 23°/a of the control groups were relieved of the
swelling. On the fifth post-operative day, 98% were relieved of swelling in
the experimental group against 46% in the control group. Statistical analysis
and inference has shown significant difference in the experience of swelling
between the two groups.
TABLE-1
Relief from Trismus and Swelling with R. Compound
in terms of % of case observed
|
Days of assessment |
Restoration of Degree of
mouth opening to pre-operative
level Expt. Gr. Control Gr. |
Reduction of Swelling to Pre-operative level Expt. Gr. Control Gr. |
||
|
1 st day |
All experienced mild to moderate Trismus |
All experienced moderate to severe Trismus |
40% moderate, the rest had mild swelling |
53% had severe 47% moderate swelling. |
|
|
||||
|
|
||||
|
2nd day |
28 |
Nil |
68 |
12 |
|
3rd day |
68 |
Nil |
87 |
23 |
|
4th day |
76 |
22 |
94 |
40 |
|
5th day |
87 |
36 |
98 |
46 |
|
7th day |
96 |
66 |
100 |
65 |
TRISMUS: Trisums is mainly due to muscular spasm brought
about by the painful stimuli. It is very likely as R. Compound seems to posses
analgesic qualities, the patients in the treated group experienced less
trismus. R. Compound did not prevent the onset of trismus. All the patients
experienced inability to open the mouth on the first post-operative day but the
degree of trismus was less in the experimental group on the second
post-operative day, 28% in t4e experimental group could open the mouth against
none in the control group. On the third post-operative day 68% in the
experimental group could open their mouth normally compared to none in the
control group. Trismus was relieved in 87% of the experiment and 36% of the
control group by the fifth post-operative day. Trismus persisted only in 4% of
the experimental group against 34% in the control group by the seventh
post-operative day. This shows that though R. Compound did not prevent the
onset of trismus, it is of definite help in the early recovery from it.The
difference in the results observed in the two groups was statistically
significant.
PAIN: All the patinets experienced pain, ranging from
32% mild to 68% moderately severe in the experimental group and 13% moderately
severe to 87% severe in the control group, on the first post operative day. 22%
of the experimental group were free of pain on the second post-operative day,
compared to none in the control group. The beneficial effects were more evident
on the third day. In 48% of the experimental group there was no pain against
11 % in the control group. The pain persisted only in 10% of the experimental
group compared to 73% in the control group on the fifth post-operative day. On
the 7th post operative day there was none in the experimental group against 33%
in the control group who complained of pain. The difference was statistically
significant on all the post operative days. (Table II)
Relief from pain with R. Compound experienced as %
of cases observed
|
Days of assessment |
Expt. Group No pain Mild Moderate
Severe |
Control Group No pain Mild
Moderate Severe |
||||||
|
1 st day |
Nil |
32 |
68 |
Nil |
Nil |
Nil |
13 |
87 |
|
2nd day |
22 |
51 |
27 |
Nil |
Nil |
16 |
46 |
38 |
|
3rd day |
48 |
43 |
9 |
Nil Nil 11 |
11 Nil 11 |
24 |
40 |
25 |
|
4th day |
67 |
26 |
7 |
Nil |
14 |
43 |
27 |
16 |
|
5th day |
90 |
7 |
3 |
Nil |
27 |
49 |
18 |
6 |
|
7th day |
100 |
Nil |
Nil |
Nil |
67 |
24 |
9 |
Nil |
The observations in this study
in general are similar to the beneficial effects of this drug reported by
various authors 1,12,14 therby confirming the efficacy of the drug
R. Compound has a definite place in the management of surgical cases in
dentistry. The well formulated Ayurvedic drugs and preparations are known for
their freedom from toxicity and side effects. The majority of the analgesic and
anti-inflammatory drugs available in the market, posses undesirable
side-effects like nausea, vomiting and gastric irritation and are potentially
toxic
CHART N0.1
Showing Complete Relief from Trismus, Swelling and
Pain
in the Experimental group and the Control group on
7th Post Operative day.
Control Group
100% 100%

Pain
agents. As observed in this
study, while having favourable and beneficial effects on the post-operative
conditions, no side-effects of any kind were observed with R. Compound. Though
this is a definite observation, it needs further study specially in comparison
with analgesic and anti-inflammatory drugs available in the modern medicine.
R. Compound has been
subjected to a clinical trial on 60 patients undergoing surgical removal of
impacted mandibular third molars. R. Compound, in the present study, was found
to be of definite value in the management of post-operative complications like
trismus swelling and pain. Though the patients treated with R. Compound
experienced inability to open the mouth, the degree of trismus was much less
and the recovery uneventful. The drug is of great help in the early resolution
of the oedema as evidenced in this study. Even though all patients experienced
pain, the pain was much less in the experimental group. By the seventh
post-operative day, none experienced pain the experimental group against 33%
who had pain in the control group.
A conclusion therefore,
can be drawn that R. Compound has definite value in the management of
post-operative trismus, oedema and pain. However, further clinical trials are
necessary to standardise the dosage and duration of therapy. It would be of
interest to compare the efficacy of this drug with the commonly used
anti-inflammatory drugs. No side effects of any kind that can be attributed to
the drug were noticed during the present study.
Our thanks are due to Dr.
A. Krishna Rao, Dean, Kasturba Medical College, Manipal, for his constant
encouragement, help and for allowing us to carry out this trial on R.
Compound. We are also thankful to Mr. P. G. Shukla of Alarsin Pharmaceuticals,
Bombay for his help and untiring efforts in the smooth completion of the trials
and supply of R. Compound.
1. Ethi Rajulu, G.: A
clinical study with"R. Compound" -in the treatment of Rheumatoid
Arthritis and other chronic Arthritis; Paper read at IVth Annual conference
of the Association of Orthopaedic Surgeons of A. P. held at Hyderabad on 7th
& 8th July, 1972
2. Fleuchaus, P. T.:
Effect of hyaluronidase on swelling and trismus after removal of impacted
mandibularthird molars O.S., O.M., 0. P., 9 : 493, 1956.
3. Freedman Davia:
Combination of Prednisolone and vitamin therapy in the control of
post-operative oedema. Journal of oral Surgery, Anaesthesia and Hospital O.
Surgery, 18 : 332, July, 1960.
4, Hennessy, Thomas: External
heat and cold therapy in Oral Surgery. Amer. J. of Orthodontia and Oral Surg.
27 : 472, Sept., 1941
'nnerfield: Buca1y
administered ~'#eotokinase, The New England journal ,. ; Medicine, 258:1069,
1958.
-~ ~~r;:si'irmg & Hinds: Clinical evaluation of anamines in
Oral Surgery using the douunknown technque, J.C3. S. 15 : 2?9, Oct., 1957.
% . °;,rause, D.J.:
Controlled study on removal d f mandihu6ar third molars. Effen.t of enzyme
mixture on sequeiaw, J.A Cj.A.. 63 : 70, Dec., 1961.
8. Lucian Szmyd: Clinical
evaluation of an an
![]()
tihistaminic preparation
in Oral Surgery, O.S. O.M. O.P., 9:928, Sept., 1956.
9. Mead, Sterling: Hydrotherapy, Amer.J.Ortho and Oral Surg., 25.,: 797, Aug,
1939.
10. Patrick, D. Toto: Clinical
evaluation of antiinflammatory enzyme therapy in inflammation and pain: J. of
Dental Medicine, Vol. 1-7,1962.
11. Patrick, S. M. &
Horton, R. B.: Plant enzymes in Oral Surgery, O.S., O.M., O.P., 309, Mar.,
1965.
12. Ramchandra, K.: R.
Compound in Rheumatoid Arthritis; personal communication; Mediscope, 15 : 6,
September, 1972.
13. Ross, et al:
Evaluation of hydrocortisone in prevention of post-operative complication after
Oral Surgery. J. O. S. 16 : 220, May.
1958.
14. Sardesai, H. V.: Use
of R. Compound in Rheumatoid Arthritis; Paper read at 1st congress of South
East Asia and Pacific Area League against Rheumatism held at Bombay, 17-21
Feb., 1968.
15. Shuttee: Hyaluronidase
in relief of postoperative trismus, swelling and pain, O.S., 0. M., 0. P.,
114, Jan., 1962.
16. Silverman, R. E.:
Further clinical observations on the use of antihistamines in Oral Surgery;
Preliminary report. J. O. S. 12 : 310.
1954.
17. Snyder, B. S.: Effect
of antihistamine agents on inflammatory response after surgical trauma. J. O.
S., Anesthe & Hosp. D. Serr. 18 : 319, July, 1960.
18. Tejinder Singh:
Evaluation of papain in the control of post-operative oedern-~. Disseration
M.D.S. Oral Surgery, (An t-~~rsity of Bombay, Apr, 1967.
19. Wohigemuth, P.R.:
Post-operative oedema in maxillo-facial surgery. American Journal of Surgery,
94: 537, 1957.
for information on ALARSIN products please write to
:
ALARSIN. Alarsin House, A/32, Road No. 3, M. L D.
C., Andheri (E), Bombay-400 093.